NCT00826644 2021-08-09
COMBAT
Chonnam National University Hospital
Phase 3 Completed
Clinical Trials
6 trialsNCT01497873 2018-12-27
A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer
Chong Kun Dang Pharmaceutical
Phase 2 Completed
NCT01630018 2016-09-22
Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial
Chong Kun Dang Pharmaceutical
Phase 2 Completed
NCT01022671 2016-01-28
Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy
Chong Kun Dang Pharmaceutical
Phase 2 Completed
NCT00754858 2014-12-02
Belotecan and Cisplatin in Treating Patients With Previously Untreated, Extensive-Stage Small Cell Lung Cancer
Yonsei University
Phase 2 Completed
NCT00430144 2012-04-26
Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix
National Cancer Center, Korea
Phase 2 Completed